Panacea Life Sciences Holdings Inc (EXDI) Return on Investment ROI from the first quarter of 2024 to first quarter of 2023 and for the year 2024, average high and low, overall ranking from Mar 31 2024 to Mar 31 2023 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Panacea Life Sciences Holdings Inc   (EXDI)


Panacea Life Sciences Holdings Inc's ROI from its first quarter of 2024 to the first quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Panacea Life Sciences Holdings Inc's ROI in the first quarter of 2024?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Panacea Life Sciences Holdings Inc 's return on investment (ROI) in its first quarter of 2024

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter
Y / Y Investment Change TTM - -90.81 % -75.72 % -73.64 % -59.65 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -6 -1 0 1 3
Return On Investment (TTM) - - -371.61 % -293.41 % -170.94 %
EXDI's Overall Ranking # 4460 # 0 # 4328 # 4297 # 4991
Seq. Investment Change TTM - -72.73 % -26.36 % -42.44 % -20.53 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -8 -8 -8 -8 -8

EXDI Company Profile >> Back to EXDI Roi Comparisons >> See Annual EXDI Return On Investment



Return On Investment EXDI's Ranking
Within: No.
Industry # 17
Sector # 167
Overall # 4460

Return On Investment Statistics
High Average Low
-16.82 %
-529.57 %
-5748.81 %
(Mar 31 2022)   (Jun 30 2021)







Financial Statements
Panacea Life Sciences Holdings Inc's I. Quarter Investments $ -6 Millions EXDI's Balance sheet
Panacea Life Sciences Holdings Inc's I. Quarter Income $ -1 Millions Quarterly EXDI's Income Statement
EXDI's Income by Division See EXDI's Income by Division


EXDI Annual Return On Investment (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019
Total Investments in Millions -1 4 14 -7 3
Y / Y Investment Growth - -67.8 % - - -
Net Income in Millions -8 -9 -5 -8 -9
Y / Y Net Income Growth - - - - -
Annual Return On Investment - -207.05 % -34.88 % - -282.01 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Legal Cannabis Industry Roi Trends and Statistics
Consumer Non Cyclical Sector Return On Investment Statistics
Roi Trends for overall market
EXDI's Roi Ratio versus Legal Cannabis Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for EXDI's Competitors
Subscribers only: Roi for Panacea Life Sciences Holdings Inc's Suppliers
Subscribers only: Return On Investment for EXDI's Customers

Other Ratios
EXDI's Roa EXDI's Inventory Turnover Ratio EXDI's Growth Rates EXDI's Dividend Statistics
EXDI's Profitability Ratios EXDI's Asset Turnover Ratio EXDI's Dividend Growth
EXDI's Roe EXDI's Valuation Ratios EXDI's Financial Strength Ratios EXDI's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2024, within Consumer Non Cyclical Sector ROI
Dswiss Inc   100.18 %

Date modified: 2026-09-08T15:11:16+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.